Current understanding and management of medullary thyroid cancer.

Roy, Madhuchhanda; Chen, Herbert; Sippel, Rebecca S

Roy, Madhuchhanda; Chen, Herbert; Sippel, Rebecca S.

Affiliation

Roy M; Department of Surgery, University of Wisconsin, Madison, Wisconsin, USA.

Oncologist ; 18(10): 1093-100, 2013.

Article in En | MEDLINE | ID: mdl-24037980

Subject(s)

Carcinoma, Medullary/congenital; Multiple Endocrine Neoplasia Type 2a/genetics; Multiple Endocrine Neoplasia Type 2a/pathology; Proto-Oncogene Proteins c-ret/genetics; Thyroid Neoplasms/genetics; Thyroid Neoplasms/pathology; Thyroidectomy; Calcitonin/blood; Carcinoma, Medullary/blood; Carcinoma, Medullary/genetics; Carcinoma, Medullary/pathology; Carcinoma, Medullary/surgery; Carcinoma, Neuroendocrine; Germ-Line Mutation; Humans; Lymph Node Excision; Multiple Endocrine Neoplasia Type 2a/blood; Multiple Endocrine Neoplasia Type 2a/surgery; Proto-Oncogene Mas; Thyroid Neoplasms/blood; Thyroid Neoplasms/surgery

Key words

Familial Medullary Thyroid Cancer (FMTC); Medullary Thyroid Cancer (MTC); Multiple Endocrine Neoplasia Syndrome; Prophylactic surgery in MTC; RET proto-oncogene; Serum calcitonin

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Thyroidectomy / Thyroid Neoplasms / Carcinoma, Medullary / Multiple Endocrine Neoplasia Type 2a / Proto-Oncogene Proteins c-ret Type of study: Guideline Limits: Humans Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google